Literature DB >> 8549757

Mutagenesis analysis of the membrane-proximal ligand binding site of the TGF-beta receptor type III extracellular domain.

M C Pepin1, M Beauchemin, C Collins, J Plamondon, M D O'Connor-McCourt.   

Abstract

There are two TGF-beta binding subdomains in the extracellular domain of receptor type III (proximal and distal in relation to the transmembrane domain). Here we present an extension of our analysis of the proximal binding site of receptor type III. Due to the original deletion mutagenesis strategy, our proximal binding site contained 19 amino acids from the N-terminal part of the receptor. By deleting these, we demonstrated that they did not contribute to the binding ability of the proximal binding site. We also produced a soluble, secreted form of the proximal binding site and demonstrated that it was able to bind TGF-beta. Finally, we analyzed the role of the three asparagine residues (580, 591, 595) that are located in the region of the receptor that is necessary for expression of a functional proximal binding site, and found that mutation of these residues individually to alanine did not affect ligand binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549757     DOI: 10.1016/0014-5793(95)01378-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.

Authors:  A Taniguchi; K Matsuzaki; K Nakano; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

Review 2.  Roles for the type III TGF-beta receptor in human cancer.

Authors:  Catherine E Gatza; Sun Young Oh; Gerard C Blobe
Journal:  Cell Signal       Date:  2010-02-12       Impact factor: 4.315

3.  Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.

Authors:  Erik V Verona; Yuping Tang; Thomas K Millstead; Andrew P Hinck; Joseph K Agyin; Lu-Zhe Sun
Journal:  Protein Eng Des Sel       Date:  2008-05-21       Impact factor: 1.650

4.  Identification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3).

Authors:  Uschi Diestel; Marcus Resch; Kathrin Meinhardt; Sigrid Weiler; Tina V Hellmann; Thomas D Mueller; Joachim Nickel; Jutta Eichler; Yves A Muller
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

5.  TGFBR3 variation is not a common cause of Marfan-like syndrome and Loeys-Dietz-like syndrome.

Authors:  Krishna K Singh; Joerg Schmidtke; Britta Keyser; Mine Arslan-Kirchner
Journal:  J Negat Results Biomed       Date:  2012-02-02

6.  Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling.

Authors:  Maria M Villarreal; Sun Kyung Kim; Lindsey Barron; Ravi Kodali; Jason Baardsnes; Cynthia S Hinck; Troy C Krzysiak; Morkos A Henen; Olga Pakhomova; Valentín Mendoza; Maureen D O'Connor-McCourt; Eileen M Lafer; Fernando López-Casillas; Andrew P Hinck
Journal:  Biochemistry       Date:  2016-12-02       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.